BioMedEcon, a leading provider of health economics and outcomes research, presented findings from a landmark nine-year retrospective claims analysis that compared the median per-patient health care costs for patients with obsessive-compulsive disorder (OCD) versus depression. This study, supported by Jazz Pharmaceuticals, Inc., was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting on May 3-7, in Toronto.
Popularity: unranked [?]
Related posts:
- BioMedEcon Reports Three Times Higher Healthcare Costs Among Patients With Obsessive-Compulsive Disorder Compared To Patients With Depression
- Patients In St. Jude Medical Deep Brain Stimulation For Depression Pilot Study Demonstrate Sustained Improvement In Depression Symptoms
- Depression, Schizophrenia, Obsessive Compulsive Disorders, Anxiety & Autism Information Now More Available!
- Older HIV-Positive Adults Experience High Levels Of Depression, Age-Related Medical Conditions, Study Says
- Older HIV-Positive Adults Experience High Levels Of Depression, Age-Related Medical Conditions, Study Says

Comments
No Responses to “BioMedEcon Reports 200% Higher Outpatient Medical Costs Among Patients With Obsessive-Compulsive Disorder Compared To Matched Patients With Depression”